Effect of anesthesia in stroke models

Neuromethods

Volumn 47, Issue , 2010, Pages 121-138

  Traystman, Richard J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Anesthetic mechanisms of action; Cerebral neuroprotection; Focal and global cerebral ischemia; In vivo animal stroke models; Volatile and nonvolatile anesthetics

Indexed keywords

ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; DESFLURANE; ETOMIDATE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETAMINE; MIDAZOLAM; PROPOFOL; SEVOFLURANE; XENON;

ANESTHESIA INDUCTION; ANESTHESIA MECHANISM; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN METABOLISM; DISEASE MODEL; DRUG EFFICACY; DRUG MEGADOSE; EXPERIMENTAL MODEL; HEMODYNAMICS; HUMAN; IN VIVO STUDY; MOLECULAR BIOLOGY; NERVE STIMULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STROKE;

ANIMALIA;

EID: 77954234066     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-60761-750-1_10     Document Type: Review

References (159)

1. Wells BA, Keats AC, Cooley DA (1963) Increased tolerance to cerebral ischemia produced by general anesthesia during temporary carotid occlusion. Surgery 54: 216-223
2. Patel P, Drummond JC, Cole DJ, Kelly PJ, Watson M (1998) Isoflurane and pentobarbital reduce the frequency of transient ischemic depolarizations during focal ischemia in rats. Anesth Analg 86: 773-780
3. Ochiai C, Asano T, Takakura K, Fukuda T, Horizoe H, Morimoto Y (1982) Mechanisms of cerebral protection by pentobarbital and nizofenone correlated with the course of local cerebral blood flow changes. Stroke 13:788-795
4. Warner DS, Hansen TD, Vust L, Todd MM (1989) The effects of isoflurane and pentobarbital on the distribution of cerebral blood flow during focal cerebral ischemia in the rat. J Neurosurg Anesth 1:219-226
5. Wilson JX, Gelb AW (2002) Free radicals, antioxidants, and neurologic injury: possible relationships to cerebral protection by anesthetics. J Neurosurg Anesth 14:66-79
6. Kahraman S, Demiryurek AT (1997) Propofol is a peroxynitrite scavenger. Anesth Analg 84:1127-1129
7. Harada H, Kelly PJ, Cole DJ, Drummond JC, Patel PM (1999) Isoflurane reduces N-methyl- D-aspartate toxicity in vivo in the rat cerebral cortex. Anesth Analg 89:1442-1447
8. Bickler PE, Buck LT, Hansen BM (1994) Effects of isoflurane and hypothermia on glutamate receptor-mediated calcium influx in brain slices. Anesthesiology 81:1461-1469
9. Jenkins A, Greenblatt EP, Faulkner HJ, Bertaccini E, Light A, Lin A, Andreasen A, Viner A, Trudell JR, Harrison NL (2001) Evidence for a common binding cavity for three general anesthetics within the GABAA receptor. J Neurosci 21:RC136
10. Harris BD, Moody EJ, Basile AS, Skolnick P (1994) Volatile anesthetics bidirectionally and stereospecifically modulate ligand binding to GABA receptors. Eur J Pharmacol 267:269-274
11. Gyulai FE, Mintun MA, Firestone LL (2001) Dose dependent enhancement of in vivo GABAA-benzodiazepine receptor binding by isoflurane. Anesthesiology 95:585-593
12. Sugimura M, Kitayama S, Morita K, Imai Y, Irifune M, Takavada T, Kawahara M, Dohi T (2002) Effects of GABAergic agents on anesthesia induced by halothane, isoflurane, and thiamylal in mice. Pharmacol Biochem Behav 72:111-116
13. Hirota K, Roth SH (1997) Sevoflurane modulates both GABAA and GABAB receptors in CA 1 or rat hippocampus. Br J Anaesth 78:60-65
14. Wang L, Traystman RJ, Murphy SJ (2008) Inhalational anesthetics as preconditioning agents in ischemic brain. Curr Opin Pharmacol 8:104-110
15. Kitano H, Kirsch JR, Hum PD, Murphy SJ (2007) Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab 27:1108-1128
16. Bhardwaj A, Castro IA, Alkayed NJ, Hum PD, Kirsch JR (2001) Anesthetic choice of halothane versus propofol: impact on experimental perioperative stroke. Stroke 32:1920-1925
17. Kapinya KJ, Lowl D, Futterer C, Maurer M, Waschke KF, Isaev NK, Dirnagl U (2002) Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 33:1889-1898
18. Zheng S, Zuo Z (2003) Isoflurane preconditioning reduces Purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience 118:99-106
19. Brunet A, Datta SR, Greenberg ME (2001) Transcription-dependent and independent control of neuronal survival by the P13k-AKt signaling pathway. Curr Opin Neurobiol 11:297-305
20. Garcia L, Burda J, Hrehorovska M, Burda R, Martin ME, Salinas M (2004) Ischaemic preconditioning in the rat brain: effect on the activity of several initiation factors, AKt and extracellular signal-regulated protein kinase phosphorylation, and GRP78 and GADD34 expression. J Neurochem 88:136-147
21. Nakajima T, Iwabuchi S, Miyazaki H, Okuma Y, Kuwabara M, Nomura Y, Kawahara K (2004) Preconditioning prevents ischemiainduced neuronal death through persistent AKt activation in the penumbra region of the rat brain. J Vet Med Sci 66:521-527
22. Huang PL (2004) Nitric oxide and cerebral ischemic preconditioning. Cell Calcium 36:232-239
23. Xiong L, Zheng Y, Wu M, Hou L, Zhu Z, Zhang X, Lu Z (2003) Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 96:233-237
24. Kehl F, Payne RS, Roever N, Schurr A (2004) Sevoflurane-induced preconditioning of rat brain in vitro and the role of KATP channels. Brain Res 1021:76-81
25. Wang ZP, Zhang ZH, Zeng YM, Jiang S, Wang SQ, Wang S (2006) Protective effect of sevoflurane preconditioning on oxygenglucose deprivation injury in rat hippocampal slices: the role of mitochondrial KATP channels. Sheng Li Xue Bao 58:201-206
26. Liu Y, Xiong L, Chen S, Wang Q (2006) Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists. Can J Anaesth 53:194-201
27. Zheng S, Zuo Z (2004) Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol Pharmacol 65:1172-1180
28. Clarkson AN (2007) Anesthetic-mediated protection/preconditioning during cerebral ischemia. Life Sci 80:1157-1175
29. Perez-Pinzon MA (2007) Mechanisms of neuroprotection during ischemic preconditioning: lessons from anoxic tolerance. Comp Biochem Physiol A Mol Integr Physiol 147:291-299
30. Goldstein A Jr, Wells BA, Keats AS (1966) Increased tolerance to cerebral anoxia by pentobarbital. Arch Int Pharmacodyn Ther 161:138-143
31. Goldstein A Jr, Wells BA, Keats AS (1964) Effect of anesthesia on tolerance of dog brain to anoxia. Anesthesiology 25:98
32. Wright RL, Ames A III (1964) Measurement of maximal permissible cerebral ischemia and a study of its pharmacologic prolongation. J Neurosurg 22:567-574
33. Wechsler RL, Dripps RD, Kety SS (1951) Blood flow and oxygen consumption of the human brain during anesthesia produced by thiopental. Anesthesiology 12:308-314
34. Smith AL, Marque JJ (1976) Anesthetics and cerebral edema. Anesthesiology 45:64-72
35. Shapiro HM (1975) Intracranial hypertension: therapeutic and anesthetic considerations. Anesthesiology 43:445-471
36. Todd MM, Chadwick HS, Shapiro HM, Dunlop BJ, Marshall LF, Dueck R (1982) The neurologic effects of thiopental therapy following experimental cardiac arrest in cats. Anesthesiology 57:76-86
37. Kofke WA, Nemoto EM, Hossmann KA, Taylor F, Kessler PD, Stezoski SW (1979) Brain blood flow and metabolism after global ischemia and post-insult thiopental therapy in monkeys. Stroke 10:554-560
38. Nordstrom CH, Calderini G, Rehncrona S, Siesjo BK (1977) Effects of phenobarbital anesthesia on post-ischemic cerebral blood flow and oxygen consumption in the rat. Acta Neurol Scand Suppl 64:148-149
39. Nemoto EM (1979) Studies on the pathogenesis of ischemic brain damage and its amelioration by barbiturate therapy. In: Zuelch KJ, Kaufman W, Hossmann KA, Hossmann V (eds) Brain and heart infarct II. Springer, Berlin, pp 306-317
40. Nemoto EM, Shiu GK, Nemmer JP, Bleyaert AL (1983) Free fatty acid accumulation in the pathogenesis and therapy of ischemic-anoxic brain injury. Am J Emerg Med 1:175-179
41. Traystman RJ (2004) Anesthetic mediated neuroprotection: established fact or passing fancy? J Neurosurg Anesthesiol 16:308-312
42. Warner DS (2004) Anesthetics provide limited but real protection against acute brain injury. J Neurosurg Anesthesiol 16: 303-307
43. Fukuda S, Warner DS (2007) Cerebral protection. Br J Anaesth 99:10-17
44. Head B, Patel P (2007) Anesthetics and brain protection. Curr Opin Anaesthesiol 20:395-399
45. Steen PA, Michenfelder JD (1979) No barbiturate protection in a dog model of complete cerebral ischemia. Ann Neurol 5:343-349
46. Bleyaert AL, Nemoto EM, Safar P, Stezoski SM, Mickell JJ, Moossy J, Rao GR (1978) Thiopental amelioration of brain damage after global ischemia in monkeys. Anesthesiology 49:390-398
47. Breivik H, Safar P, Sands P, Fabritius R, Linol B, Lust P, Mollies A, Orr M, Renck H, Snyder JV (1978) Clinical feasibility trials of barbiturate therapy after cardiac arrest. Crit Care Med 6:228-244
48. Snyder BD, Ramirez-Lassepas M, Sukhum P, Fryd D, Sung JH (1979) Failure of thiopental to modify global anoxic injury. Stroke 10:135-141
49. Gisvold SE, Safar P, Hendrickx HH, Rao G, Moossy J, Alexander H (1984) Thiopental treatment after global brain ischemia in pigtailed monkeys. Anesthesiology 60:88-96 (Pubitemid 14176316)
50. Brain Resuscitation Clinical Trial I Study Group (1986) Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 314: 397-403
51. Smith AL, Hoff JT, Nielsen SL, Larson CP (1974) Barbiturate protection in acute focal cerebral ischemia. Stroke 5:1-7
52. Hoff JT, Smith AL, Hankinson HL, Nielsen SL (1975) Barbiturate protection from cerebral infarction in primates. Stroke 6:28-33
53. Michenfelder JD, Milde JH, Sundt TM (1976) Cerebral protection by barbiturate anesthesia: use after middle cerebral artery occlusion in JAVA monkeys. Arch Neurol 33:345-350
54. Carkill G, Sivalingam S, Reitan JA, Gilroy BA, Helphrey MG (1978) Dose dependency of the post-insult protective effect of pentobarbital in the canine stroke model. Stroke 9:10-12
55. Selman WR, Spetzler RF, Roski RA, Roessmann V, Crumrine R, Macko R (1982) Barbiturate coma in focal cerebral ischemia: relationship of protection to timing of therapy. J Neurosurg 56:685-690
56. Warner DS, Zhou JG, Ramani R, Todd MM (1991) Reversible focal ischemia in the rat: effects of halothane, isoflurane and methohexital anesthesia. J Cereb Blood Flow Metab 11:794-802
57. Drummond JC, Cole DJ, Patel PM, Reynolds LW (1995) Focal cerebral ischemia during anesthesia with etomidate, isoflurane or thiopental: a comparison of the extent of cerebral injury. Neurosurgery 37:742-748
58. Kawaguchi M, Fukuya H, Patel PM (2005) Neuroprotective effects of anesthetic agents. J Anesth 19:150-156
59. Chen L, Gong Q, Xiao C (2003) Effects of propofol, midazolam, and thiopental sodium on outcome and amino acids accumulation in focal cerebral ischemia-reperfusion in rats. Chin Med J 116:292-296
60. Drummond JC (1993) Do barbiturates really protect the brain? Anesthesiology 78:611-613
61. Nillson L, Siesjo BK (1975) The effect of phenobarbitone on blood flow and oxygen consumption in the rat brain. Acta Anaesthesiol Scand Suppl 57:18-24
62. Zhu H, Cotrell JE, Kass IS (1997) The effect of thiopental and propofol on NMDA- and AMPA-mediated glutamate excitotoxicity. Anesthesiology 87:944-951
63. Kimbro JR, Kelly PJ, Drummond JC, Cole DJ, Patel PM (2000) Isoflurane and pentobarbital reduce AMPA toxicity in vivo in the rat cerebral cortex. Anesth Analg 89:1442-1447
64. Zhan RZ, Fujiwara N, Endoh H, Yamakura T, Taga K, Fukuda S, Shimoji K (1998) Thiopental inhibits increases in Ca++ induced by membrane depolarization, NMDA receptor activation and ischemia in rat hippocampal and cortical slices. Anesthesiology 89:456-466
65. Smith DS, Rehncrona S, Westerberg E, Akesson B, Siesjo BK (1979) Lipid peroxidation in brain tissue in vitro: antioxidant effects of barbiturates. Acta Physiol Scand 105:527-529 (Pubitemid 9165236)
66. Meldrum B (1982) Pharmacology of GABA. Clin Neuropharmacol 5:293-316
67. Concas A, Santoro G, Serra M, Sanna E, Biggio G (1991) Neurochemical action of the general anesthetic propofol on the chloride ion channel coupled with GABAA receptors. Brain Res 542:225-232
68. Orser BA, Wang LY, Pennefather PS, MacDonald JF (1994) Propofol modulates activation and desensitization of GABAA receptors in cultured murine hippocampal neurons. J Neurosci 14:7747-7760
69. Orser BA, Bertlik M, Wang LY, MacDonald JF (1995) Inhibition by propofol (2, 6 diisopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurons. Br J Pharmacol 116:1761-1768
70. Boisset S, Steghens JP, Favetta P, Terreux R, Guitton J (2004) Relative antioxidant capacities of propofol and its main metabolites. Arch Toxicol 8:835-842
71. Adembri C, Venture L, Pellegrini-Giampietro DE (2007) Neuroprotective effects of propofol in acute cerebral injury. CNS Drug Rev 13:333-351
72. Feiner JR, Bickler PE, Estrada S, Donohoe PH, Fahlman CS, Schuyler JA (2005) Mild hypothermia, but not propofol, is neuroprotective in organotypic hippocampal cultures. Anesth Analg 100:215-225
73. Kochs E, Hoffman WE, Werner C, Thomas C, Albrecht RF, Schulte EJ (1992) The effects of propofol on brain electrical activity, neurologic outcome, and neuronal damage following incomplete ischemia in rats. Anesthesiology 6:245-252
74. Young Y, Menon DK, Tisavipat N, Matta BF, Jones JG (1997) Propofol neuroprotection in a rat model of ischemia reperfusion injury. Anesthesiology 4:320-326
75. Yano T, Nakayama R, Ushijima K (2000) Intracerebroventricular propofol is neuroprotective against transient global ischemia in rats: extracellular glutamate level is not a major determinant. Brain Res 883:69-76
76. Ito H, Watanabe Y, Isshiki A, Uchino H (1999) Neuroprotective properties of propofol and midazolam, but not pentobarbital on neuronal damage induced by forebrain ischemia based on the GABAA receptors. Acta Anesthesiol Scand 43:153-162
77. Gelb AW, Bayona NA, Wilson JX, Cechetto DF (2002) Propofol anesthesia compared to awake reduces infarct size in rats. Anesthesiology 96:1183-1190
78. Tsai YC, Huang SI, Lai YY, Chang CL, Cheng JT (1994) Propofol does not reduce infarct volume in rats undergoing permanent middle cerebral artery occlusion. Acta Anaesthesiol Sin 2:99-104
79. Zhan R, Qi S, Wu C, Fujihara H, Taga K, Shimoji K (2001) Intravenous anesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-D-aspartate receptor inhibition. Crit Care Med 9:808-813
80. Bayona NA, Gelb AW, Jiang Z, Wilson JX, Urquhart BL, Cechetto DF (2004) Propofol neuroprotection in cerebral ischemia and its effects on low-molecular weight antioxidants and skilled motor tasks. Anesthesiology 100:1151-1159
81. Kanbak M, Saricaoglu F, Avci A, Ocal T, Koray Z, Aypar U (2004) Propofol offers no advantage over isoflurane anesthesia for cerebral protection during cardiopulmonary bypass: a preliminary study of S100 beta protein levels. Can J Anesth 1:712-717
82. Engelhard K, Weiner C, Eberspacher E, Bachl M, Blobner M, Hildt E, Hutzler P, Kochs E (2003) The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonists (+)-ketamine on the expression of sapoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rat. Anesth Analg 96:524-531
83. Himmelscher S, Pfenninger E, Georgieff M (1996) The effects of ketamine-isomers on neuronal injury and regeneration in rat hippocampal neurons. Anesth Analg 83:505-512
84. Kolenda H, Gremmrlt A, Raching S, Braun D, Markakis E (1996) Ketamine for analgosedative therapy in intensive care treatment of head-injured patients. Acta Neurochir (Wien) 138:1193-1199
85. Botero CA, Smith CE, Holbrook C, Chavez AM, Snow NJ, Hagen JF, Pinchak AC (2000) Total intravenous anesthesia with a propofolketamine combination during coronary artery surgery. J Cardiothorac Vasc Anesth 14:409-415
86. Laffey JC, Boglan JF, Cheng DC (2002) The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 97:215-252
87. Xu J, Wen Y, Cibelli M, Ma D, Maze M (2006) Postoperative cognitive dysfunction: a role for cytokine-mediated inflammation in the hippocampus. Anesthesiology 105:A1175
88. Church J, Zeman S, Lodge D (1988) The neuroprotective action of ketamine and MK -801 after transient cerebral ischemia in rats. Anesthesiology 69:702-709
89. Hoffman W, Pelligrino D, Werner C, Kochs E, Albrecht RF, SchulteamEsh J (1992) Ketamine decreases plasma catecholamines and improves outcome from incomplete cerebral ischemia in rats. Anesthesiology 76:755-762
90. Lees GJ (1995) Influence of ketamine on the neuronal death caused by NMDA in the rat hippocampus. Neuropharmacology 34:411-417
91. Chan P, Chu L (1998) Ketamine protects cultured astrocytes from glutamate induced swelling. Brain Res 487:380-383
92. Shibuta S, Varathan S, Mashimo T (2006) Ketamine and thiopental sodium: individual and combined neuroprotective effects on cortical cultures exposed to NMDA or nitric oxide. Br J Anaesth 97:517-524
93. Wang L, Jing W, Hang YN (2008) Glutamateinduced c-Jun expression in neuronal PC12 cells: the effect of ketamine and propofol. J Neurosurg Anesthesiol 20:124-130
94. Hudetz JA, Iqbal SD, Patterson KM, Burne AJ, Hudetz AG, Pagel PS, Warltier DC (2009) Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery. Acta Anesthesiol Scand. doi:10.1111/j.1399-6576
95. Himmelscher S, Durieux ME (2005) Revising a dogma: ketamine for patients with neurological injury? Anesth Analg 101:524-534
96. Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anesthetics ketamine and phencyclidine selectively reduce excitation of central mammalian neurons by N-methyl aspartate. Br J Pharmacol 79:565-575
97. Clifford DB, Zorumski CF, Olney JW (1989) Ketamine and MK-801 prevent degeneration of thalamic neurons induced by cortical seizures. Exp Neurol 105:272-279
98. Shapiro Y, Lam AM, Eng CC, Lashaprasit Y, Michel M (1994) Therapeutic time window and dose response of the beneficial effects of ketamine in experimental head injury. Stroke 25:1637-1643
99. Proescholdt M, Heimann A, Kempski O (2001) Neuroprotection of S(+) ketamine isomer in global forebrain ischemia. Brain Res 904:245-251
100. Jensen ML, Auer RN (1988) Ketamine fails to protect against ischemic neuronal necrosis in the rat. Br J Anaesth 61:206-210
101. Ridenour TR, Warner DS, Todd MM, Baker MT (1991) Effects of ketamine on outcome from temporary middle cerebral artery occlusion in the spontaneously hypertensive rat. Brain Res 565:116-122
102. Church J, Zeman S (1991) Ketamine promotes hippocampal CA1 pyramidal neuron loss after a short-duration ischemic insult in rats. Neurosci Lett 123:65-68
103. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70-74 (Pubitemid 29044848)
104. Pohl D, Bittigau P, Ishimura MJ, Stadthaus D, Hubner C, Olney JW, Turski L, Ikonomidou C (1999) N-methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci USA 96:2508-2513
105. Young C, Jevtovic-Todorovic V, Qin YQ, Tenkova T, Wang H, Labruyere J, Olney JW (2005) Potential of ketamine and midazolam individually or in combination to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol 146:189-197
106. Slikkor W Jr, Zou X, Hotchkiss CE, Divine RL, Sadovova N, Twaddle NC, Doerge DR, Scallet AC, Patterson TA, Hanig JP, Paule MG, Wang C (2007) Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci 98:145-158
107. Wang C, Sadovova N, Hotchkiss CE, Fu X, Scallet AC, Patterson TA, Hanig J, Paule MG, Slikkor W Jr (2006) Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol Sci 91:192-201
108. Pfenninger E, Reith A (1990) Ketamine and intracranial pressure. In: Domino EF (ed) Status of ketamine in anesthesiology. NPP Books, Ann Arbor, pp 109-117
109. Reicher D, Bhalla P, Rubinstein EH (1987) Cholinergic cerebral vasodilator effects of ketamine in rabbits. Stroke 18:445-447
110. Dawson B, Michenfelder RA, Theye RA (1971) Effect of ketamine on canine cerebral blood flow and metabolism: modification by prior administration of thiopental. Anesth Analg 50:443-447
111. Schwedler M, Miletich DJ, Albrecht RF (1982) Cerebral blood flow and metabolism following ketamine administration. Can Anaesth Soc J 29:222-226
112. Crosby G, Crane AM, Sokoloff L (1982) Local changes in cerebral glucose utilization during ketamine anesthesia. Anesthesiology 56:437-443 (Pubitemid 12123184)
113. Nelson SR, Howard RB, Cross RS, Samson F (1980) Ketamine-induced changes in regional glucose utilization in the rat brain. Anesthesiology 52:330-334
114. Fleischer JE, Milde JH, Moyer TP, Michenfelder JD (1988) Cerebral effects of high-dose midazolam and subsequent reversal with RO 15-1788 in dogs. Anesthesiology 68:234-242
115. Obraclovi DI, Savi MM, Andjelkovi DS, Ugresi ND, Bokoji DR (2003) The influence of midazolam and flumazenil on rat brain slice oxygen consumption. Pharmacol Res 47:127-131
116. Lei B, Popp S, Cottrell JE, Kass IS (2009) Effects of midazolam on brain injury after transient focal cerebral ischemia in rats. J Neurosurg Anesth. doi:10.1097/ ANA. obo13e318191697a
117. Abramowicz AE, Kass IS, Chambers G, Cottrell JE (1991) Midazolam improves electrophysiologic recovery after anoxia and reduces the changes in APT levels and calcium influx during anoxia in the rat hippocampal slice. Anesthesiology 74:1121-1128
118. Rekling JC (2003) Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation. Neurosci Lett 335:167-170
119. Xue QS, Yu BW, Wang ZJ, Chen HZ (2004) Effects of ketamine, midazolam, thiopental, and propofol on brain ischemia injury in rat cerebral cortex slices. Acta Pharmacol Sin 25:115-120
120. Drummond JC, McKay LD, Cole DJ, Patel PM (2005) The role of nitric oxide synthase inhibition in the adverse effects of etomidate in the setting of focal cerebral ischemia in rats. Anesth Analg 100:841-846
121. Lenz C, Rebel A, VanAckern K, Kuschinsky W, Waschke KF (1998) Local cerebral blood flow, local cerebral glucose utilization and flow metabolism coupling during sevoflurane versus isoflurane anesthesia in rats. Anesthesiology 89:1480-1488 (Pubitemid 29001587)
122. Hendrick KS, Kochanek PM, Melick JA, Scheding JK, Statler KD, Williams DS, Marion DW, Ho C (2001) Cerebral perfusion during anesthesia with fentanyl, isoflurane, or pentobarbital in normal rats studied by arterial spin-labeled MRI. Magn Reson Med 46:202-206
123. Patel PM, Drummond JC, Goskowicz R, Sano T, Cole DJ (1993) The volatile anesthetic isoflurane reduces ischemia induced release of glutamate in rats. J Cereb Blood Flow Metab S685
124. Bickler PE, Warner DS, Stratmann G, Schulyer JA (2003) Gamma-aminobutyric acid-A receptors contribute to isoflurane neuroprotection in organotypic hippocampal cultures. Anesth Analg 97:564-571
125. Baughman VL, Hoffman WE, Thomas C, Miletich DJ, Albrecht RF (1990) Comparison of methohexital and isoflurane on neurologic outcome and histopathology following incomplete ischemia in rats. Anesthesiology 72:85-94 (Pubitemid 20031317)
126. Warner DS, McFarlane G, Todd MM, Ludwig P, McAllister AM (1993) Sevoflurane and halothane reduce focal ischemic brain damage in the rat: possible influence on thermoregulation. Anesthesiology 79:985-992
127. Warner DS, Ludwig PS, Pearlstein R, Brinkhous AD (1995) Halothane reduces focal ischemic injury in the rat when brain temperature is controlled. Anesthesiology 82:1237-1245
128. Newberg LA, Michenfelder JD (1983) Cerebral protection by isoflurane during hypoxemia or ischemia. Anesthesiology 59:229-235
129. Nehls DG, Todd MM, Spetzler RF, Drummond JC, Thompson RA, Johnson PC (1987) A comparison of the cerebral protective effects of isoflurane and barbiturates during temporary focal ischemia in primates. Anesthesiology 66:453-464
130. Milde LN, Milde JH, Lanier WL, Michenfelder JD, Gallagher W, Koenig R, Kroening A, Phelps L, Wilson R (1988) Comparison of the effects of isoflurane and thiopental on neurologic outcome and neuropathology after temporary focal ischemia in primates. Anesthesiology 69:905-913
131. Michenfelder JD, Sundt TM, Fode N, Sharbrough FW (1987) Isoflurane when compared to enflurane and halothane decreases the frequency of cerebral ischemia during carotid endarterectomy. Anesthesiology 67:336-340
132. Gelb AW, Boisvert DP, Tang C, Lam AM, Marchak BE, Dowman R, Mielke BW (1989) Primate brain tolerance to temporary focal cerebral ischemia during isoflurane or sodium nitroprusside induced hypotension. Anesthesiology 70:678-683
133. Sarraf-Yazdi S, Sheng H, Miura Y, McFarlane C, Dexter F, Pearlstein R, Warner DS (1998) Relative neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat. Anesth Analg 87:72-78
134. Kawaguchi M, Drummond JC, Cole DJ, Kelly PJ, Spurlock MP, Patel PM (2004) Effect of isoflurane on neuronal apoptosis in rats subjected to local cerebral ischemia. Anesth Analg 98:798-805
135. Kawaguchi M, Kimbro JR, Drummond JC, Cole DJ, Kelly PJ, Patel PM (2000) Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology 92:1335-1342
136. Elsersy H, Sheng H, Lynch JR, Moldovan M, Pearlstein RD, Warner DS (2004) Effects of isoflurane versus fentanyl-nitrous oxide anesthesia on long-term outcome from severe forebrain ischemia in the rat. Anesthesiology 100:1160-1166
137. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF (2003) Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 23:876-882
138. Wise-Faberowski L, Zhang H, lng R, Pearlstein RD, Warner DS (2005) Isofluraneinduced neuronal degeneration: an evaluation in organotypic hippocampal slice cultures. Anesth Analg 101:651-657
139. Franks NP, Lieb WR (1994) Molecular and cellular mechanism of general anesthesia. Nature 367:607-614
140. Franks NP, Dickinson R, de Souza SLM, Hall AC, Lieb WR (1998) How does xenon produce anesthesia? Nature 396:324
141. Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski CF, Olney JW (1998) Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 4:460-463
142. Mennerick S, Jeutovic-Todorovic V, Todorovic SM, Shen LG, Olney JW, Zorumski CF (1998) Effects of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci 18:9716-9726
143. Ishimaru MJ, Ikonomidou C, Tenkove TI, Der TC, Dikranian K, Sesma MA, Olney JW (1999) Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol 408:461-476 (Pubitemid 29211175)
144. Sanders RD, Maze M (2005) Xenon: from stranger to guardian. Curr Opin Anesthesiol 18:405-411
145. Wilhelm S, Ma D, Maze M, Franks NP (2002) Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 96:1485-1491
146. Homi HM, Yokoo N, Ma D, Warner DS, Franks NP (2003) The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 99:876-881
147. Dingley J, Tooley J, Porter H, Thoresen M (2006) Xenon provides short term neuroprotection in neonatal rat when administered after hypoxia-ischemia. Stroke 37:501-506
148. David HN, Haelewyn B, Rouillon C, Lecoq M, Chazalviel L, Apiou G, Risso JJ, Lemair M, Abraini JH (2008) Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J 22:1275-1286
149. Fries M, Nolte KW, Coburn M, Rex S, Timper A, Korrmann K, Stepmann K, Hausler M, Weis J, Rossaint P (2008) Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs. Crit Care Med 36:2420-2426
150. Ma D, Hossain M, Chow A, Arshad M, Battsen RM, Saunders RD, Mehmete H, Edwards AD, Franks NP, Maze M (2005) Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 58:182-193
151. Hobbs C, Thoresen M, Tucker A, Aquilina K, Chakkarapani E, Dingley J (2008) Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ ischemia. Stroke 39:1307-1313
152. Rajakumaraswamy N, Ma D, Hossain M, Sanders RD, Franks NP, Maze M (2006) Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models. Neurosci Lett 409:128-133
153. Ma D, Hossain M, Pettet GK, Luo Y, Akimov S, Sanders RD, Franks NP, Maze M (2006) Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab 26:199-208
154. Payne RS, Akca O, Roewer N, Schurr A, Kahl F (2005) Sevoflurane-induced preconditioning protects against cerebral ischemic neuronal damage in rats. Brain Res 1034: 147-152
155. Wang J, Lei B, Popp S, Ming F, Cottrell JE, Kass IS (2007) Sevoflurane immediate preconditioning alters hypoxic membrane potential changes in rat hippocampal slices and improves recovery of CA1 pyramidal cells after hypoxia and global cerebral ischemia. Neuroscience 145:1097-1107
156. Wei H, Kang B, Wei W, Liang G, Ming QC, Li Y, Eckenhoff RG (2005) Isoflurane and sevoflurane affect cell survival and BCL-2/ BAX ratio differently. Brain Res 1037:139-147
157. Kurth CD, Priestley M, Watzman HM, McCann J, Golden J (2001) Desflurane confers neurologic protection for deep hypothermic circulatory arrest in newborn pigs. Anesthesiology 95:959-964
158. Loepke AW, Priestley M, Schultz SE, McHann J, Golden J, Kurth CD (2002) Desflurane improves neurologic outcome after low-flow cardiopulmonary bypass in newborn pigs. Anesthesiology 97: 1521-1527
159. Haelewyn B, Yvon A, Hanouz TL, MacKenzie ET, Ducouret P, Gerard JL, Roussel S (2003) Desflurane affords greater protection than halothane against focal cerebral ischemia in the rat. Br J Anaesth 91:390-396